Rifapentine (Priftin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rifapentine (Priftin), covering 2024-09-26 to 2024-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI [Phase 2, Phase 3]